Companies / F-star Therapeutics, Inc.
F-star Therapeutics, Inc.
FSTXCIK 1566373
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Forster Eliot CEO | Other Shares tendered | Common Stock | $2.47M | -348K -82.45% | 73,959 | low |
| Mar 8, 2023 | Brewis Neil Executive | Other Shares tendered | Common Stock | $748.2K | -105K -91.81% | 9,375 | low |
| Mar 8, 2023 | Bermingham Nessan Director | Other Shares tendered | Common Stock | $694.5K | -98K -93.91% | 6,328 | low |
| Mar 8, 2023 | Forster Eliot CEO | Other Sold to issuer | Common Stock | $526.6K | -74K -100.00% | 0 | low |
| Mar 8, 2023 | Deptula-Hicks Darlene M Executive | Other Shares tendered | Common Stock | $220.0K | -31K -54.75% | 25,539 | low |
| Mar 8, 2023 | Kayitalire Louis Executive | Other Shares tendered | Common Stock | $208.2K | -29K -53.89% | 25,019 | low |
| Mar 8, 2023 | Deptula-Hicks Darlene M Executive | Other Sold to issuer | Common Stock | $181.8K | -26K -100.00% | 0 | low |
| Mar 8, 2023 | Kayitalire Louis Executive | Other Sold to issuer | Common Stock | $178.1K | -25K -100.00% | 0 | low |